Hyperprogressive Disease in Patients With Advanced NSCLC Treated With PD-1/PD-L1 Inhibitors
Interview with Benjamin Besse, MD, author of Hyperprogressive Disease in Patients With Advanced Non–Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or With Single-Agent Chemotherapy
don't worry if you don't have an account with us, we'll create one
[{"meta":{"author":"JAMA Oncology Author Interviews","authorlink":""},"src":"http:\/\/traffic.libsyn.com\/jamaoncologyauthorinterviews\/Hyperprogressive_Disease_in_Patients_With_Advanced_NSCLC_Treated_With_PD-1_PD-L1_Inhibitors.mp3?dest-id=422099","thumb":{"src":"https:\/\/lystnimg.b-cdn.net\/podcastsnw-202106\/2c18c9-9ed2-8d77-8f6ccb_800.jpg"},"title":"Hyperprogressive Disease in Patients With Advanced NSCLC Treated With PD-1\/PD-L1 Inhibitors","link":"javascript:;","id":"item-437990"}]
